Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 239

Results For "SEC"

3010 News Found

Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh
News | March 24, 2022

Kiran Mazumdar-Shaw elected as the Fellow of Royal Society of Edinburgh

Kiran will be joining RSE's current Fellowship of around 1,700 Fellows who are recognized as being some of the greatest thinkers, researchers and practitioners working in or with Scotland


Arum Therapeutics implements CDD Vault to streamline research data
Biotech | March 23, 2022

Arum Therapeutics implements CDD Vault to streamline research data

Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers


Roquette to invest €25 million in liquid, polyols production
News | March 23, 2022

Roquette to invest €25 million in liquid, polyols production

The investment will improve equipment efficiency and increase safety standards at its Lestrem site


Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
News | March 23, 2022

Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction

The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease


Hester Biosciences foray into pet care industry
News | March 22, 2022

Hester Biosciences foray into pet care industry

Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Lonza signs manufacturing agreement with Oasmia Pharmaceutical
News | March 21, 2022

Lonza signs manufacturing agreement with Oasmia Pharmaceutical

Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply